RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma

OBJECTIVES: RAD51 overexpression has been reported to serve as a marker of poor prognosis in several cancer types. This study aimed to survey the role of RAD51 in oral squamous cell carcinoma and whether RAD51 could be a potential therapeutic target. MATERIALS AND METHODS: RAD51 protein expression,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Yu-Fen, Chan, Leong-Perng, Chen, Yuk-Kwan, Su, Chang-Wei, Hsu, Ching-Wei, Wang, Yen-Yun, Yuan, Shyng-Shiou F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552296/
https://www.ncbi.nlm.nih.gov/pubmed/37798649
http://dx.doi.org/10.1186/s12935-023-03071-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552296/
https://www.ncbi.nlm.nih.gov/pubmed/37798649
http://dx.doi.org/10.1186/s12935-023-03071-w

Ejemplares similares